MURPHY NICOLE 1910644 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 638.0 | 8.08 | 0.04 | 240.3 | Direct | Common Stock | BIOGEN INC. | code F | 7256.9895 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 2101.0 | 26.61 | 0.14 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 7894.9895 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 761.0 | 7.99 | 0.05 | 240.98 | Direct | Common Stock | BIOGEN INC. | code F | 8767.9895 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 2272.0 | 23.84 | 0.16 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9528.9895 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 610.0 | 6.08 | 0.04 | 219.08 | Direct | Common Stock | BIOGEN INC. | code F | 9417.9895
|
145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 1260.0 | 13.11 | 0.09 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9613.9895
|
145.36 (BIIB) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 117.0 | 1.2 | 0.01 | 214.83 | Direct | Common Stock | BIOGEN INC. | code F | 9634.3741 | 145.36 (BIIB) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 240.0 | 2.46 | 0.02 | 0.0 | Direct | Common Stock | BIOGEN INC. | code M | 9751.3741 | 145.36 (BIIB) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-31 | 2024-01-29 | 2024-01-29 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 856.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code A | 856.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-08 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 2101.0 | 33.32 | 0.14 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 4204.0 | 144.9 (BIIB) |
| 2024-02-09 | 2024-02-07 | 2024-02-07 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | acq | 5820.0 | 100.0 | 0.4 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code A | 5820.0 | 144.9 (BIIB) |
| 2024-02-13 | 2024-02-09 | 2024-02-09 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 2272.0 | 50.0 | 0.16 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 2272.0 | 144.9 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 856.0 | 100.0 | 0.06 | 0.0 | Direct | Performance Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
| 2024-02-21 | 2024-02-16 | 2024-02-16 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 908.0 | 100.0 | 0.06 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code J M | 0.0
|
145.36 (BIIB) |
| 2024-04-03 | 2024-04-01 | 2024-04-01 | 4 | Murphy Nicole | HEAD OF PHARM OPS AND TECH | dsp | 240.0 | 100.0 | 0.02 | 0.0 | Direct | Restricted Stock Unit | BIOGEN INC. | code M | 0.0 | 145.36 (BIIB) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)